Aromatase Inhibitors for Treatment of Uterine Leiomyomas
Status:
Withdrawn
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Fibroids are benign tumors that might results in bleeding. Surgery is their definitive
treatment. Some medical therapies have been tried for women who wish to preserve their
uterus. Recent reports have demonstrated a role for a new category of drugs called aromatase
inhibitor (such as Femara) in the treatment of fibroids. This study is conducted to assess
the effect of Femara (letrozole) on the size of fibroids in women around menopause.